Market Overview:
The global magnetic resonance imaging (MRI) contrast agents market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in MRI contrast agents. However, the high cost of MRI contrast agents may restrain the growth of this market during the forecast period. Based on type, the global magnetic resonance imaging (MRI) contrast agents market is segmented into injection type and oral type. Injection type is further sub-segmented into gadolinium-based and non-gadolinium based Contrast Agents (CAs). Gadolinium-based CAs are more commonly used as they offer high image quality and are less likely to cause adverse effects as compared to non-gadolinium based CAs. Oral type is further sub-segmented into macrocyclic GBCAs and small molecule GBCAs. Macrocyclic GBCA’s are more commonly used as they offer high image quality and are less likely to cause adverse effects as compared to small molecule GBCA’s . Based on application, the global magnetic resonance imaging (MRI)contrast agentsmarketis segmentedinto hospitalsand clinics .
 Contrast Agents Industry Outlook.svg)
Product Definition:
Contrast agents work by altering the magnetic properties of nearby tissues, making them easier to distinguish from surrounding structures. MRI contrast agents are typically given intravenously and can help improve the accuracy of diagnoses for a wide range of medical conditions.
Injection Type:
Injection type is a method of delivering contrast agents used in Magnetic Resonance Imaging (MRI) and CT scans. The most common injection types are intravenous, intra-arterial, subcutaneous, and intramuscular injections. Intravenous injection has the highest market share among all other injection types due to its ease of use and wide availability across the globe.
Oral Type:
Oral type is a contrast agent used in MRI to improve the signal-to-noise ratio. It is also known as tastant and it binds to taste receptors on the tongue which enhances or intensifies the signals received by the brain. Oral type allows better imaging of soft tissues like blood vessels, tumors, and dura mater during an MRI scan because of its high sensitivity towards sugar (glucose) molecules than other intravenous or intraarterial injectionable agents.
Application Insights:
The clinics segment dominated the global market in 2017. This is owing to a high preference for outpatient imaging over inpatient procedures. In addition, the availability of more than one MRI contrast agent solution per day that can be used at the convenience of patients also contributes to its growth. The hospitals segment is expected to witness lucrative growth during the forecast period due to an increase in demand for non-invasive diagnostic solutions over traditional methods such as X-ray and CT scan among others.
MRI contrast agents are primarily used for diagnosis of various conditions including spinal cord injuries, brain tumor, disc degenerative disease and osteoarthritis among others by providing enhanced images with greater clarity than conventional imaging techniques such as X-ray and CT scan do.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing adoption of novel MRI compatible drugs, and presence of well-established healthcare facilities. In addition, growing prevalence of neurological disorders is expected to drive demand for contrast agents in this region. For instance, as per the Alzheimer's Association website around 5 million people are suffering from Alzheimer's disease (AD) in U.S., which is expected to increase during the forecast period. AD is a degenerative brain disorder that affects cognitive functioning leading to loss of memory and mental faculties such as reasoning ability and thinking clearly etc.
In Asia Pacific & Middle East & Africa (APMEA), growth can be attributed majorly to developing economies such as India.
Growth Factors:
- Increasing demand for MRI scans for early detection of diseases
- Rising prevalence of chronic diseases such as cancer, Alzheimer's disease, and heart disease
- Growing number of MRI centers worldwide
- Technological advancements in MRI contrast agents
- Increasing awareness about the benefits of MRI contrast agents
Scope Of The Report
Report Attributes
Report Details
Report Title
Magnetic Resonance Imaging (MRI) Contrast Agents Market Research Report
By Type
Injection Type, Oral Type
By Application
Hospitals, Clinics
By Companies
GE, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Report Segments:
The global Magnetic Resonance Imaging (MRI) Contrast Agents market is segmented on the basis of:
Types
Injection Type, Oral Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE
- Bayer
- Bracco Imaging
- Guerbet Group
- Hengrui Medicine
- Lantheus
- YRPG
- BeiLu Pharma
 Contrast Agents Market Overview.svg)
Highlights of The Magnetic Resonance Imaging (MRI) Contrast Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection Type
- Oral Type
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Magnetic Resonance Imaging (MRI) Contrast Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Contrast Agents Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Magnetic resonance imaging (MRI) contrast agents are substances that increase the contrast between tissues in an image.
Some of the key players operating in the magnetic resonance imaging (mri) contrast agents market are GE, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma.
The magnetic resonance imaging (mri) contrast agents market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Magnetic Resonance Imaging (MRI) Contrast Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Magnetic Resonance Imaging (MRI) Contrast Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Size & Forecast, 2018-2028
4.5.1 Magnetic Resonance Imaging (MRI) Contrast Agents Market Size and Y-o-Y Growth
4.5.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market Absolute $ Opportunity
Chapter 5 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Type
5.2.1 Injection Type
5.2.2 Oral Type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Magnetic Resonance Imaging (MRI) Contrast Agents Analysis and Forecast
9.1 Introduction
9.2 North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Type
9.6.1 Injection Type
9.6.2 Oral Type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Analysis and Forecast
10.1 Introduction
10.2 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Type
10.6.1 Injection Type
10.6.2 Oral Type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Type
11.6.1 Injection Type
11.6.2 Oral Type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Analysis and Forecast
12.1 Introduction
12.2 Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Type
12.6.1 Injection Type
12.6.2 Oral Type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Magnetic Resonance Imaging (MRI) Contrast Agents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Type
13.6.1 Injection Type
13.6.2 Oral Type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Magnetic Resonance Imaging (MRI) Contrast Agents Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Magnetic Resonance Imaging (MRI) Contrast Agents Market: Competitive Dashboard
14.2 Global Magnetic Resonance Imaging (MRI) Contrast Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE
14.3.2 Bayer
14.3.3 Bracco Imaging
14.3.4 Guerbet Group
14.3.5 Hengrui Medicine
14.3.6 Lantheus
14.3.7 YRPG
14.3.8 BeiLu Pharma
